Vivo Bio Tech is conducting a postal ballot to get shareholder approval for re-appointing a director and approving related party transactions, including with Virinchi Limited.

Vivo Bio Tech Seeks Shareholder Approval for Key Governance and Transactions

Vivo Bio Tech Limited is seeking shareholder approval through a postal ballot process for several important resolutions, including the re-appointment of a director and significant related party transactions. Shareholders can cast their votes electronically from June 15, 2026, to July 14, 2026.

What Just Happened

The company has initiated a postal ballot to secure shareholder consent for:

• Re-appointment of Mr. Kalyan Ram Mangipudi as Whole-time Director.
• Appointment of Mrs. Madhavi Latha Kompella as Advisor.
• Approval of transactions with Virinchi Limited.

Why This Matters

These resolutions are crucial for Vivo Bio Tech's corporate governance and future operational structure. Shareholder approval is required for these appointments and financial dealings, impacting the company's strategic direction and financial arrangements.

The Backstory

Mr. Kalyan Ram Mangipudi is proposed for re-appointment as Whole-time Director for five years, from July 29, 2026, to July 28, 2031. His remuneration is proposed to be capped at ₹1 lakh per month. Mrs. Madhavi Latha Kompella, a promoter, is to be appointed as Advisor for five years from October 1, 2026, with a monthly compensation of ₹15 lakh. Additionally, transactions with Virinchi Limited, a promoter group entity, are proposed with an aggregate limit of ₹30 crore for FY 2026-27, including software consultancy and inter-corporate loans.

What Changes Now

Upon shareholder approval, the proposed appointments and transactions will be formalized, allowing the company to proceed with its strategic and operational plans. The specific financial limits and tenures for the director, advisor, and related party transactions will be legally enacted.

Risks to Watch

Investors should monitor the significant remuneration proposed for the promoter-advisor role at ₹15 lakh per month, assessing its value addition. The ₹30 crore transaction limit with Virinchi Limited is also substantial relative to the company's scale and warrants careful observation for arm's length dealings.

Peer Comparison

While specific peer data for these types of promoter appointments and related party transaction limits are not provided in the filing, investors may wish to compare the proposed remuneration and transaction scales against industry norms for companies of similar size and sector.

Context Metrics (Time-bound)

• Postal Ballot Voting Period: June 15, 2026 – July 14, 2026
• Director Re-appointment Term: July 29, 2026 – July 28, 2031
• Advisor Appointment Term: October 1, 2026 – September 30, 2031
• Proposed WTD Remuneration: ₹1 lakh per month
• Proposed Advisor Remuneration: ₹15 lakh per month
• Material RPT Limit (Virinchi Ltd): ₹30 crore for FY 2026-27
• Virinchi Standalone Turnover (FY26): ₹164 crore
• Virinchi Standalone PAT (FY26): ₹6.73 crore

What to Track Next

Investors should closely follow the outcome of the postal ballot. Post-approval, tracking the actual expenditure on advisory services and the nature and financial impact of transactions with Virinchi Limited will be crucial.